Search Results - "Farrugia, Mark K"

Refine Results
  1. 1

    Association of neutrophil-lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy by Huang, Karen, Prasad, Sharan, Ma, Sung Jun, Yu, Han, Iovoli, Austin J, Farrugia, Mark K, Dexter, Elizabeth U, Demmy, Todd L, Malik, Nadia K, Singh, Anurag K

    Published in BMC cancer (18-03-2023)
    “…The role of neutrophil-lymphocyte ratio (NLR) as a predictor for survival in single fraction SBRT-treated non-small cell lung cancer (NSCLC) patients remains…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    MicroRNAs 206 and 21 Cooperate To Promote RAS-Extracellular Signal-Regulated Kinase Signaling by Suppressing the Translation of RASA1 and SPRED1 by Sharma, Sriganesh B., Lin, Chen-Chung, Farrugia, Mark K., McLaughlin, Sarah L., Ellis, Emily J., Brundage, Kathleen M., Salkeni, Mohamad A., Ruppert, J. Michael

    Published in Molecular and cellular biology (01-11-2014)
    “…Despite the low prevalence of activating point mutation of RAS or RAF genes, the RAS-extracellular signal-regulated kinase (ERK) pathway is implicated in…”
    Get full text
    Journal Article
  5. 5

    Association of radiation dose intensity with overall survival in patients with distant metastases by Kao, Johnny, Farrugia, Mark K., Frontario, Samantha, Zucker, Amanda, Copel, Emily, Loscalzo, John, Sangal, Ashish, Darakchiev, Boramir, Singh, Anurag, Missios, Symeon

    Published in Cancer medicine (Malden, MA) (01-11-2021)
    “…Background Patients with metastatic cancer referred to radiation oncology have diverse prognoses and there is significant interest in personalizing treatment…”
    Get full text
    Journal Article
  6. 6

    A Dose-Response Relationship to Radiotherapy for Cutaneous Lesions of Langerhans Cell Histiocytosis by Farrugia, Mark K., Morrison, Carl, Hernandez-Ilizaliturri, Francisco, Aljabab, Saif

    Published in Case reports in oncological medicine (25-03-2021)
    “…Langerhans cell histiocytosis (LCH) is a rare disease, afflicting approximately 4.6 and 1-2 per 1 million children and adults, respectively. While LCH can…”
    Get full text
    Journal Article
  7. 7

    Long-Term Survival and Failure Outcomes of Single-Fraction Stereotactic Body Radiation Therapy in Early Stage NSCLC by Iovoli, Austin J, Prasad, Sharan, Ma, Sung Jun, Fekrmandi, Fatemeh, Malik, Nadia K, Fung-Kee-Fung, Simon, Farrugia, Mark K, Singh, Anurag K

    Published in JTO clinical and research reports (01-12-2023)
    “…This study aims to report our 13-year institutional experience with single-fraction stereotactic body radiation therapy (SF-SBRT) for early stage NSCLC. A…”
    Get full text
    Journal Article
  8. 8

    Candida meningitis in an immunocompetent patient detected through (1→3)-beta-d-glucan by Farrugia, Mark K., Fogha, Evan P., Miah, Abdul R., Yednock, Joel, Palmer, H. Carl, Guilfoose, John

    “…•Candida meningitis can be a rare complication of intravenous drug abuse in an immunocompetent individual.•Testing of the cerebrospinal fluid for…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Kruppel-like Pluripotency Factors as Modulators of Cancer Cell Therapeutic Responses by Farrugia, Mark K, Vanderbilt, Daniel B, Salkeni, Mohamad A, Ruppert, J Michael

    Published in Cancer research (Chicago, Ill.) (01-04-2016)
    “…Tumor cells inherit from their normal precursors an extensive stress response machinery that is critical for survival in response to challenges including…”
    Get full text
    Journal Article
  11. 11

    Re-Evaluating the Omission of Radiation Therapy in Low-Risk Patients With Early-Stage Breast Cancer by Almeida, Neil D., Pepin, Abigail, Schrand, Tyler V., Shekher, Rohil, Goulenko, Victor, Fung-Kee-Fung, Simon, Farrugia, Mark K., Shah, Chirag, Singh, Anurag K.

    Published in Clinical breast cancer (01-10-2024)
    “…Traditionally, management of early-stage breast cancer has required adjuvant radiation therapy following breast conserving surgery, due to decreased local…”
    Get full text
    Journal Article
  12. 12

    Evaluation of risk stratification using gene expression assays in patients with breast cancer receiving neoadjuvant chemotherapy by Ma, Sung Jun, Serra, Lucas M., Yu, Brian, Bartl, Austin J., Farrugia, Mark K., Oladeru, Oluwadamilola T., Singh, Anurag K.

    Published in Breast cancer research and treatment (01-10-2021)
    “…Purpose To evaluate the association of various gene expression assays with pathologic complete response (pCR) in the setting of neoadjuvant chemotherapy among…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Concurrent β-blocker Use is Associated With Improved Outcome in Esophageal Cancer Patients Who Undergo Chemoradiation: A Retrospective Matched-pair Analysis by Farrugia, Mark K., Ma, Sung Jun, Mattson, David M., Flaherty, Leayn, Repasky, Elizabeth A., Singh, Anurag K.

    Published in American journal of clinical oncology (01-12-2020)
    “…β-blocker use has been associated with improved outcomes in a number of different malignancies; however, the impact of β-blockade in esophageal cancer is not…”
    Get full text
    Journal Article
  17. 17

    Severe Oral Mucositis After Intensity-Modulated Radiation Therapy for Head and Neck Cancer by Iovoli, Austin J., Turecki, Lauren, Qiu, Michelle L., Khan, Michael, Smith, Kelsey, Yu, Han, Ma, Sung Jun, Farrugia, Mark K., Singh, Anurag K.

    Published in JAMA network open (11-10-2023)
    “…Importance Oral mucositis (OM) is a common and debilitating adverse effect observed in patients with head and neck cancer (HNC) receiving radiation therapy…”
    Get full text
    Journal Article
  18. 18

    Prophylactic High-Dose Gabapentin Reduces Opiate Use during Radiation Therapy for Head and Neck Squamous Cell Carcinoma by Qiu, Michelle L, Iovoli, Austin J, Khan, Michael, Farrugia, Mark K, Ma, Sung Jun, Singh, Anurag K

    Published in Cancers (28-03-2023)
    “…The role of prophylactic high-dose gabapentin for the management of oral mucositis during radiation therapy for head and neck squamous cell carcinoma (HNSCC)…”
    Get full text
    Journal Article
  19. 19

    Narrative review of the management of oral mucositis during chemoradiation for head and neck cancer by Judge, Lauren F, Farrugia, Mark K, Singh, Anurag K

    Published in Annals of translational medicine (01-05-2021)
    “…Oral mucositis (OM) can be a significant problem for patients undergoing radiation or chemoradiation for head and neck cancer. In modern clinical trials, grade…”
    Get full text
    Journal Article
  20. 20

    Comparative Analysis of the Views of Oncologic Subspecialists and Palliative/Supportive Care Physicians Regarding Advanced Care Planning and End-of-Life Care by Pifer, Phillip M., Farrugia, Mark K., Mattes, Malcolm D.

    “…Background: Early palliative/supportive care (PSC) consultation and advance care planning (ACP) improve outcomes for patients with incurable cancer. However,…”
    Get full text
    Journal Article